Efficacy, effectiveness, and safety of Ustekinumab for the treatment of ulcerative colitis: A systematic review

JP Gisbert, E Parody-Rúa… - Inflammatory Bowel …, 2024 - academic.oup.com
Objective This study aimed to evaluate ustekinumab efficacy, effectiveness, and safety as a
treatment for ulcerative colitis in adult patients. Methods A systematic review of the efficacy …

[HTML][HTML] Constrained multiple instance learning for ulcerative colitis prediction using histological images

R Del Amor, P Meseguer, TL Parigi, V Villanacci… - Computer methods and …, 2022 - Elsevier
Abstract Background and Objective: Ulcerative colitis (UC) is an inflammatory bowel disease
(IBD) affecting the colon and the rectum characterized by a remitting-relapsing course. To …

Comparative effectiveness and safety of ustekinumab at different intervals of maintenance phase in inflammatory bowel disease: a systematic review and meta …

Y Bai, Y Sun, Q He, X Bai, H Yang - European Journal of …, 2024 - journals.lww.com
Ustekinumab has two alternative drug maintenance intervals for inflammatory bowel disease
(IBD), every 8 weeks (Q8W) and every 12 weeks (Q12W). The current study aimed at …

Deep learning strategies for overcoming diagnosis challenges with limited annotations

MR Amor del Amor - 2023 - riunet.upv.es
[CA] En els últims anys, l'aprenentatge profund (DL) s' ha convertit en una de les principals
àrees de la intel· ligència artificial (IA), impulsat principalment per l'avanç en la capacitat de …